Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00758_DB06414> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00758_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00758_DB06414 label "DDI between Clopidogrel and Etravirine - Clopidogrel, when used concomitantly with etravirine (a CYP2C19 inhibitor), may experience a decrease in the serum concentrations of it's active metabolites. Caution and close monitoring for decreased efficacy of clopidogrel is recommended. [drugbank_resource:DB00758_DB06414]" assertion.
- drugbank_resource:DB00758_DB06414 identifier "drugbank_resource:DB00758_DB06414" assertion.
- drugbank_resource:DB00758_DB06414 title "DDI between Clopidogrel and Etravirine - Clopidogrel, when used concomitantly with etravirine (a CYP2C19 inhibitor), may experience a decrease in the serum concentrations of it's active metabolites. Caution and close monitoring for decreased efficacy of clopidogrel is recommended." assertion.